CSF3 and breast carcinoma: In these and other types of advanced breast cancers such as triple negative breast cancer [83], as well as the high-risk luminal A dominant breast cancer subtype (C3) [84], high-level expression of G-CSF in biopsy specimens is associated with poor overall survival (OS) and invasive potential.